Cite
HARVARD Citation
Guarneri, V. et al. (n.d.). LBA 2Everolimus plus aromatase inhibitors vs aromatase inhibitors as maintenance therapy after first-line chemotherapy in HR+/HER2- metastatic breast cancer: Final results of the phase III randomized MAIN-A trial. Annals of oncology. p. . [Online].